{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Sentiment Analysis"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "from nltk.sentiment.vader import SentimentIntensityAnalyzer\n",
    "\n",
    "import warnings\n",
    "warnings.filterwarnings(\"ignore\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "DatetimeIndex: 492 entries, 2009-08-17 12:14:00+00:00 to 2020-06-11 14:22:00+00:00\n",
      "Data columns (total 2 columns):\n",
      " #   Column     Non-Null Count  Dtype \n",
      "---  ------     --------------  ----- \n",
      " 0   headline   492 non-null    object\n",
      " 1   sentiment  492 non-null    object\n",
      "dtypes: object(2)\n",
      "memory usage: 11.5+ KB\n"
     ]
    }
   ],
   "source": [
    "merc_df = pd.read_csv('./data/merck_news.csv')\n",
    "merc_df['date'] = pd.to_datetime(merc_df['date'])\n",
    "merc_df.set_index('date', inplace=True)\n",
    "merc_df.sort_index(inplace=True)\n",
    "merc_df.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The Stocks That Moved The S&P, Dow And Nasdaq Today\n"
     ]
    }
   ],
   "source": [
    "# Define Merck text.\n",
    "merc_df.head()\n",
    "text = merc_df.iloc[244]['headline']\n",
    "print(text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['headline', 'sentiment'], dtype='object')"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Instantiate Sentiment Intensity Analyzer\n",
    "sia = SentimentIntensityAnalyzer()\n",
    "merc_df.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Calculate sentiment of text\n",
    "sia.polarity_scores(text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [],
   "source": [
    "merc_df['neg_sentiment'] = merc_df['headline'].apply(lambda x: sia.polarity_scores(x)['neg'])\n",
    "merc_df['neu_sentiment'] = merc_df['headline'].apply(lambda x: sia.polarity_scores(x)['neu'])\n",
    "merc_df['pos_sentiment'] = merc_df['headline'].apply(lambda x: sia.polarity_scores(x)['pos'])\n",
    "merc_df['compound_sentiment'] = merc_df['headline'].apply(lambda x: sia.polarity_scores(x)['compound'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>headline</th>\n",
       "      <th>sentiment</th>\n",
       "      <th>neg_sentiment</th>\n",
       "      <th>neu_sentiment</th>\n",
       "      <th>pos_sentiment</th>\n",
       "      <th>compound_sentiment</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>date</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2009-08-17 12:14:00+00:00</th>\n",
       "      <td>BenchmarkJournal.com Free Analyst Review for ABK, EQR, KMB, BBD, FIG and MRK</td>\n",
       "      <td>neutral</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.769</td>\n",
       "      <td>0.231</td>\n",
       "      <td>0.5106</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2009-09-18 07:38:00+00:00</th>\n",
       "      <td>Sanofi-aventis (SNY) Completes Acquisition of Merial</td>\n",
       "      <td>neutral</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.000</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.0000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2009-11-04 20:38:00+00:00</th>\n",
       "      <td>Fitch Downgrades Merck, Outlook Stable</td>\n",
       "      <td>mildly bearish</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.645</td>\n",
       "      <td>0.355</td>\n",
       "      <td>0.2960</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2009-11-04 21:02:00+00:00</th>\n",
       "      <td>Merck Says It Won't Seek Another Larger Merger</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.000</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.0000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2009-11-13 16:32:00+00:00</th>\n",
       "      <td>Merck (MRK) Drugs Under Scanner Of Cholesterol Study</td>\n",
       "      <td>neutral</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1.000</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.0000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                               headline  \\\n",
       "date                                                                                                      \n",
       "2009-08-17 12:14:00+00:00  BenchmarkJournal.com Free Analyst Review for ABK, EQR, KMB, BBD, FIG and MRK   \n",
       "2009-09-18 07:38:00+00:00                         Sanofi-aventis (SNY) Completes Acquisition of Merial    \n",
       "2009-11-04 20:38:00+00:00                                        Fitch Downgrades Merck, Outlook Stable   \n",
       "2009-11-04 21:02:00+00:00                                Merck Says It Won't Seek Another Larger Merger   \n",
       "2009-11-13 16:32:00+00:00                          Merck (MRK) Drugs Under Scanner Of Cholesterol Study   \n",
       "\n",
       "                                sentiment  neg_sentiment  neu_sentiment  \\\n",
       "date                                                                      \n",
       "2009-08-17 12:14:00+00:00         neutral            0.0          0.769   \n",
       "2009-09-18 07:38:00+00:00         neutral            0.0          1.000   \n",
       "2009-11-04 20:38:00+00:00  mildly bearish            0.0          0.645   \n",
       "2009-11-04 21:02:00+00:00  mildly bullish            0.0          1.000   \n",
       "2009-11-13 16:32:00+00:00         neutral            0.0          1.000   \n",
       "\n",
       "                           pos_sentiment  compound_sentiment  \n",
       "date                                                          \n",
       "2009-08-17 12:14:00+00:00          0.231              0.5106  \n",
       "2009-09-18 07:38:00+00:00          0.000              0.0000  \n",
       "2009-11-04 20:38:00+00:00          0.355              0.2960  \n",
       "2009-11-04 21:02:00+00:00          0.000              0.0000  \n",
       "2009-11-13 16:32:00+00:00          0.000              0.0000  "
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "merc_df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [],
   "source": [
    "# set column width\n",
    "pd.set_option('display.max_colwidth', 130)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "date\n",
       "2009-11-04 20:38:00+00:00                                                  Fitch Downgrades Merck, Outlook Stable\n",
       "2010-07-30 18:11:00+00:00                             Hapoalim Securities Downgrades Merck to Hold from Buy (MRK)\n",
       "2012-08-24 11:13:00+00:00             Bank of America Downgrades Merck & from Buy to Neutral, Announces PO of $45\n",
       "2012-08-24 16:05:00+00:00    UPDATE: Bank of America Merrill Lynch Downgrades Merck to Neutral, Reiterates $45 PT\n",
       "2013-10-14 10:52:00+00:00       Bernstein Downgrades Merck & Company, Inc. to Market Perform, Lowers PT to $50.00\n",
       "2013-10-14 11:46:00+00:00                                                               Benzinga's Top Downgrades\n",
       "2016-07-18 10:29:00+00:00                                     BMO Capital Downgrades Merck & Co to Market Perform\n",
       "2017-10-30 10:40:00+00:00                                    Morgan Stanley Downgrades Merck & Co to Equal-Weight\n",
       "2017-10-30 13:22:00+00:00                                Benzinga's Top Upgrades, Downgrades For October 30, 2017\n",
       "Name: headline, dtype: object"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "merc_df[merc_df['headline'].str.contains('Downgrades')]['headline']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [],
   "source": [
    "merc_df.to_csv('./data/merc_news_sentiment.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [],
   "source": [
    "from transformers import pipeline"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "No model was supplied, defaulted to distilbert-base-uncased-finetuned-sst-2-english and revision af0f99b (https://huggingface.co/distilbert-base-uncased-finetuned-sst-2-english).\n",
      "Using a pipeline without specifying a model name and revision in production is not recommended.\n"
     ]
    }
   ],
   "source": [
    "sia_pipeline = pipeline('sentiment-analysis')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'label': 'NEGATIVE', 'score': 0.9975982308387756}]"
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sia_pipeline(\"Bank of America Merrill Lynch Downgrades Merck to Neutral, Reiterates $45 PT\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0}"
      ]
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sia.polarity_scores(\"Bank of America Merrill Lynch Downgrades Merck to Neutral, Reiterates $45 PT\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>headline</th>\n",
       "      <th>sentiment</th>\n",
       "      <th>neg_sentiment</th>\n",
       "      <th>neu_sentiment</th>\n",
       "      <th>pos_sentiment</th>\n",
       "      <th>compound_sentiment</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>date</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2019-05-31 10:46:00+00:00</th>\n",
       "      <td>Merck Reports KEYTRUDA Showed Improved Overall Survival as First-Line Treatment of Recurrent or Metastatic Head and Neck Squam...</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.897</td>\n",
       "      <td>0.103</td>\n",
       "      <td>0.4767</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-06-01 11:36:00+00:00</th>\n",
       "      <td>Merck Announces Five-Year Survival Data for KEYTRUDA in Advanced Non-Small Cell Lung Cancer from First KEYNOTE Trial at #ASCO19</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.188</td>\n",
       "      <td>0.726</td>\n",
       "      <td>0.085</td>\n",
       "      <td>-0.5267</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-06-03 20:15:00+00:00</th>\n",
       "      <td>Merck Reports LYNPARZA Phase 3 SOLO3 Trial Showed 72% Objective Response Rate in Patients with Platinum-Sensitive Relapsed Ger...</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.136</td>\n",
       "      <td>0.802</td>\n",
       "      <td>0.062</td>\n",
       "      <td>-0.5267</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-06-04 11:45:00+00:00</th>\n",
       "      <td>The Daily Biotech Pulse: ASCO Presentations From Roche, Celgene &amp; More, Edwards Recommends Rejection Of Mini-Tender Offer</td>\n",
       "      <td>neutral</td>\n",
       "      <td>0.189</td>\n",
       "      <td>0.702</td>\n",
       "      <td>0.109</td>\n",
       "      <td>-0.3788</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-06-04 17:07:00+00:00</th>\n",
       "      <td>Shares of several healthcare companies are trading higher with the overall US market. Recent comments out of China and Mexico ...</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.820</td>\n",
       "      <td>0.180</td>\n",
       "      <td>0.6908</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-06-11 13:14:00+00:00</th>\n",
       "      <td>FDA Greenlights Merck's Blockbuster Drug Keytruda For First-Line Treatment Of Head, Neck Cancer</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.228</td>\n",
       "      <td>0.570</td>\n",
       "      <td>0.202</td>\n",
       "      <td>-0.1280</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-06-18 08:27:00+00:00</th>\n",
       "      <td>AstraZeneca, Merck Announce Lynparza Approved in the EU for 1st-line Maintenance Treatment Of BRCA-mutated Advanced Ovarian Ca...</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.190</td>\n",
       "      <td>0.603</td>\n",
       "      <td>0.207</td>\n",
       "      <td>-0.1531</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-06-19 08:58:00+00:00</th>\n",
       "      <td>AstraZeneca,Merck Announce Lynparza Approved in Japan for 1st-line Maintenance Therapy in BRCA-mutated Advanced Ovarian Cancer</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.208</td>\n",
       "      <td>0.566</td>\n",
       "      <td>0.226</td>\n",
       "      <td>-0.1531</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-06-19 19:43:00+00:00</th>\n",
       "      <td>Report: Merck Searching Internally For Next CEO</td>\n",
       "      <td>neutral</td>\n",
       "      <td>0.000</td>\n",
       "      <td>1.000</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.0000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-06-22 19:07:00+00:00</th>\n",
       "      <td>The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs</td>\n",
       "      <td>neutral</td>\n",
       "      <td>0.000</td>\n",
       "      <td>1.000</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.0000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-07-27 18:32:00+00:00</th>\n",
       "      <td>The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate</td>\n",
       "      <td>neutral</td>\n",
       "      <td>0.143</td>\n",
       "      <td>0.857</td>\n",
       "      <td>0.000</td>\n",
       "      <td>-0.1280</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-07-29 11:02:00+00:00</th>\n",
       "      <td>Merck's KEYTRUDA in Combination with Chemotherapy Met One of the Dual Primary Endpoints in Pivotal Phase 3 KEYNOTE-522</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.000</td>\n",
       "      <td>1.000</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.0000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-07-31 12:18:00+00:00</th>\n",
       "      <td>SELLAS Advances Galinpepimut-S (GPS) In Combination With KEYTRUDA Program With Dosing Of First Patient In Phase 1/2 Basket Study</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.000</td>\n",
       "      <td>1.000</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.0000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-08-14 08:40:00+00:00</th>\n",
       "      <td>Lynparza Phase Iii Paola-1 Trial Met Primary Endpoint as 1st-line Maintenance Treatment With Bevacizumab for Advanced Ovarian ...</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.196</td>\n",
       "      <td>0.714</td>\n",
       "      <td>0.089</td>\n",
       "      <td>-0.5267</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-08-29 18:57:00+00:00</th>\n",
       "      <td>Uganda Confirms Another Case Of Ebola - A 9-Year Old Girl Who Traveled Democratic Republic Of Congo</td>\n",
       "      <td>neutral</td>\n",
       "      <td>0.000</td>\n",
       "      <td>1.000</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.0000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-08-30 08:04:00+00:00</th>\n",
       "      <td>Deaths from E. Congo Ebola Outbreak Top 2,000; Cases Top 3,000</td>\n",
       "      <td>mildly bearish</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.714</td>\n",
       "      <td>0.286</td>\n",
       "      <td>0.3818</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-09-10 14:30:00+00:00</th>\n",
       "      <td>Shares of several drugmakers are trading lower on news of a drug pricing bill being developed by House Democrats. The proposed...</td>\n",
       "      <td>mildly bearish</td>\n",
       "      <td>0.060</td>\n",
       "      <td>0.813</td>\n",
       "      <td>0.127</td>\n",
       "      <td>0.3612</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-09-17 10:45:00+00:00</th>\n",
       "      <td>Merck Reports FDA Accepted Biologics License Application, Granted Priority Review For V920 For Ebola Zaire Virus</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.773</td>\n",
       "      <td>0.227</td>\n",
       "      <td>0.4767</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-09-17 15:56:00+00:00</th>\n",
       "      <td>FDA Says Granted Accelerated Approval To Lenvima In Combo With Keytruda For Treatment Of Patients With Advanced Endometrial Ca...</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.693</td>\n",
       "      <td>0.307</td>\n",
       "      <td>0.7269</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-09-20 11:46:00+00:00</th>\n",
       "      <td>The Daily Biotech Pulse: FDA Approves Merck HIV Drugs, Five Prime CEO Quits, HTG Molecular Announces Secondary Offering</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.863</td>\n",
       "      <td>0.137</td>\n",
       "      <td>0.4019</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-09-30 10:47:00+00:00</th>\n",
       "      <td>Merck's Pivotal RESTORE-IMI 2 Phase 3 Study of RECARBRIO Met its Primary Endpoint</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.000</td>\n",
       "      <td>1.000</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.0000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-10-03 15:45:00+00:00</th>\n",
       "      <td>What's Behind PDS Biotech's Rally?</td>\n",
       "      <td>neutral</td>\n",
       "      <td>0.000</td>\n",
       "      <td>1.000</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.0000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-10-03 19:49:00+00:00</th>\n",
       "      <td>Biotech Stock On The Radar: FDA Verdict Ahead For Pfenex's Osteoporosis Biosimilar</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.873</td>\n",
       "      <td>0.127</td>\n",
       "      <td>0.1531</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-10-08 15:08:00+00:00</th>\n",
       "      <td>Goldman Recommends Selling Puma Biotech, Clovis Oncology; Cites Company-Specific, Competitive Risks</td>\n",
       "      <td>mildly bearish</td>\n",
       "      <td>0.153</td>\n",
       "      <td>0.584</td>\n",
       "      <td>0.263</td>\n",
       "      <td>0.1280</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-10-11 15:19:00+00:00</th>\n",
       "      <td>Shares of several healthcare companies are trading higher after President Trump made positive remarks on the U.S.-China trade ...</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.036</td>\n",
       "      <td>0.807</td>\n",
       "      <td>0.157</td>\n",
       "      <td>0.7574</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-10-17 11:21:00+00:00</th>\n",
       "      <td>Bank of America Reinstates Neutral on Merck &amp; Co, Announces $90 Price Target</td>\n",
       "      <td>neutral</td>\n",
       "      <td>0.000</td>\n",
       "      <td>1.000</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.0000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-10-18 11:00:00+00:00</th>\n",
       "      <td>Merck Reports Positive EU CHMP Opinion For 2 New Regimens Of KEYTRUDA As First-Line Treatment For Metastatic Or Unresectable R...</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.865</td>\n",
       "      <td>0.135</td>\n",
       "      <td>0.5574</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-10-18 18:48:00+00:00</th>\n",
       "      <td>WHO Says Ebola Concentrated In Congo Mining Area, Still An Emergency</td>\n",
       "      <td>mildly bearish</td>\n",
       "      <td>0.206</td>\n",
       "      <td>0.794</td>\n",
       "      <td>0.000</td>\n",
       "      <td>-0.3818</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-10-28 15:56:00+00:00</th>\n",
       "      <td>More Earnings And A Fed Decision In Week Four Of The WeTrader Competition</td>\n",
       "      <td>neutral</td>\n",
       "      <td>0.000</td>\n",
       "      <td>1.000</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.0000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-10-29 08:57:00+00:00</th>\n",
       "      <td>Earnings Scheduled For October 29, 2019</td>\n",
       "      <td>neutral</td>\n",
       "      <td>0.000</td>\n",
       "      <td>1.000</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.0000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                    headline  \\\n",
       "date                                                                                                                                                           \n",
       "2019-05-31 10:46:00+00:00  Merck Reports KEYTRUDA Showed Improved Overall Survival as First-Line Treatment of Recurrent or Metastatic Head and Neck Squam...   \n",
       "2019-06-01 11:36:00+00:00    Merck Announces Five-Year Survival Data for KEYTRUDA in Advanced Non-Small Cell Lung Cancer from First KEYNOTE Trial at #ASCO19   \n",
       "2019-06-03 20:15:00+00:00  Merck Reports LYNPARZA Phase 3 SOLO3 Trial Showed 72% Objective Response Rate in Patients with Platinum-Sensitive Relapsed Ger...   \n",
       "2019-06-04 11:45:00+00:00          The Daily Biotech Pulse: ASCO Presentations From Roche, Celgene & More, Edwards Recommends Rejection Of Mini-Tender Offer   \n",
       "2019-06-04 17:07:00+00:00  Shares of several healthcare companies are trading higher with the overall US market. Recent comments out of China and Mexico ...   \n",
       "2019-06-11 13:14:00+00:00                                    FDA Greenlights Merck's Blockbuster Drug Keytruda For First-Line Treatment Of Head, Neck Cancer   \n",
       "2019-06-18 08:27:00+00:00  AstraZeneca, Merck Announce Lynparza Approved in the EU for 1st-line Maintenance Treatment Of BRCA-mutated Advanced Ovarian Ca...   \n",
       "2019-06-19 08:58:00+00:00     AstraZeneca,Merck Announce Lynparza Approved in Japan for 1st-line Maintenance Therapy in BRCA-mutated Advanced Ovarian Cancer   \n",
       "2019-06-19 19:43:00+00:00                                                                                    Report: Merck Searching Internally For Next CEO   \n",
       "2019-06-22 19:07:00+00:00                                              The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs   \n",
       "2019-07-27 18:32:00+00:00                                                            The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate   \n",
       "2019-07-29 11:02:00+00:00             Merck's KEYTRUDA in Combination with Chemotherapy Met One of the Dual Primary Endpoints in Pivotal Phase 3 KEYNOTE-522   \n",
       "2019-07-31 12:18:00+00:00   SELLAS Advances Galinpepimut-S (GPS) In Combination With KEYTRUDA Program With Dosing Of First Patient In Phase 1/2 Basket Study   \n",
       "2019-08-14 08:40:00+00:00  Lynparza Phase Iii Paola-1 Trial Met Primary Endpoint as 1st-line Maintenance Treatment With Bevacizumab for Advanced Ovarian ...   \n",
       "2019-08-29 18:57:00+00:00                                Uganda Confirms Another Case Of Ebola - A 9-Year Old Girl Who Traveled Democratic Republic Of Congo   \n",
       "2019-08-30 08:04:00+00:00                                                                     Deaths from E. Congo Ebola Outbreak Top 2,000; Cases Top 3,000   \n",
       "2019-09-10 14:30:00+00:00  Shares of several drugmakers are trading lower on news of a drug pricing bill being developed by House Democrats. The proposed...   \n",
       "2019-09-17 10:45:00+00:00                   Merck Reports FDA Accepted Biologics License Application, Granted Priority Review For V920 For Ebola Zaire Virus   \n",
       "2019-09-17 15:56:00+00:00  FDA Says Granted Accelerated Approval To Lenvima In Combo With Keytruda For Treatment Of Patients With Advanced Endometrial Ca...   \n",
       "2019-09-20 11:46:00+00:00            The Daily Biotech Pulse: FDA Approves Merck HIV Drugs, Five Prime CEO Quits, HTG Molecular Announces Secondary Offering   \n",
       "2019-09-30 10:47:00+00:00                                                  Merck's Pivotal RESTORE-IMI 2 Phase 3 Study of RECARBRIO Met its Primary Endpoint   \n",
       "2019-10-03 15:45:00+00:00                                                                                                 What's Behind PDS Biotech's Rally?   \n",
       "2019-10-03 19:49:00+00:00                                                 Biotech Stock On The Radar: FDA Verdict Ahead For Pfenex's Osteoporosis Biosimilar   \n",
       "2019-10-08 15:08:00+00:00                                Goldman Recommends Selling Puma Biotech, Clovis Oncology; Cites Company-Specific, Competitive Risks   \n",
       "2019-10-11 15:19:00+00:00  Shares of several healthcare companies are trading higher after President Trump made positive remarks on the U.S.-China trade ...   \n",
       "2019-10-17 11:21:00+00:00                                                       Bank of America Reinstates Neutral on Merck & Co, Announces $90 Price Target   \n",
       "2019-10-18 11:00:00+00:00  Merck Reports Positive EU CHMP Opinion For 2 New Regimens Of KEYTRUDA As First-Line Treatment For Metastatic Or Unresectable R...   \n",
       "2019-10-18 18:48:00+00:00                                                               WHO Says Ebola Concentrated In Congo Mining Area, Still An Emergency   \n",
       "2019-10-28 15:56:00+00:00                                                          More Earnings And A Fed Decision In Week Four Of The WeTrader Competition   \n",
       "2019-10-29 08:57:00+00:00                                                                                            Earnings Scheduled For October 29, 2019   \n",
       "\n",
       "                                sentiment  neg_sentiment  neu_sentiment  \\\n",
       "date                                                                      \n",
       "2019-05-31 10:46:00+00:00  mildly bullish          0.000          0.897   \n",
       "2019-06-01 11:36:00+00:00  mildly bullish          0.188          0.726   \n",
       "2019-06-03 20:15:00+00:00  mildly bullish          0.136          0.802   \n",
       "2019-06-04 11:45:00+00:00         neutral          0.189          0.702   \n",
       "2019-06-04 17:07:00+00:00  mildly bullish          0.000          0.820   \n",
       "2019-06-11 13:14:00+00:00  mildly bullish          0.228          0.570   \n",
       "2019-06-18 08:27:00+00:00  mildly bullish          0.190          0.603   \n",
       "2019-06-19 08:58:00+00:00  mildly bullish          0.208          0.566   \n",
       "2019-06-19 19:43:00+00:00         neutral          0.000          1.000   \n",
       "2019-06-22 19:07:00+00:00         neutral          0.000          1.000   \n",
       "2019-07-27 18:32:00+00:00         neutral          0.143          0.857   \n",
       "2019-07-29 11:02:00+00:00  mildly bullish          0.000          1.000   \n",
       "2019-07-31 12:18:00+00:00  mildly bullish          0.000          1.000   \n",
       "2019-08-14 08:40:00+00:00  mildly bullish          0.196          0.714   \n",
       "2019-08-29 18:57:00+00:00         neutral          0.000          1.000   \n",
       "2019-08-30 08:04:00+00:00  mildly bearish          0.000          0.714   \n",
       "2019-09-10 14:30:00+00:00  mildly bearish          0.060          0.813   \n",
       "2019-09-17 10:45:00+00:00  mildly bullish          0.000          0.773   \n",
       "2019-09-17 15:56:00+00:00  mildly bullish          0.000          0.693   \n",
       "2019-09-20 11:46:00+00:00  mildly bullish          0.000          0.863   \n",
       "2019-09-30 10:47:00+00:00  mildly bullish          0.000          1.000   \n",
       "2019-10-03 15:45:00+00:00         neutral          0.000          1.000   \n",
       "2019-10-03 19:49:00+00:00  mildly bullish          0.000          0.873   \n",
       "2019-10-08 15:08:00+00:00  mildly bearish          0.153          0.584   \n",
       "2019-10-11 15:19:00+00:00  mildly bullish          0.036          0.807   \n",
       "2019-10-17 11:21:00+00:00         neutral          0.000          1.000   \n",
       "2019-10-18 11:00:00+00:00  mildly bullish          0.000          0.865   \n",
       "2019-10-18 18:48:00+00:00  mildly bearish          0.206          0.794   \n",
       "2019-10-28 15:56:00+00:00         neutral          0.000          1.000   \n",
       "2019-10-29 08:57:00+00:00         neutral          0.000          1.000   \n",
       "\n",
       "                           pos_sentiment  compound_sentiment  \n",
       "date                                                          \n",
       "2019-05-31 10:46:00+00:00          0.103              0.4767  \n",
       "2019-06-01 11:36:00+00:00          0.085             -0.5267  \n",
       "2019-06-03 20:15:00+00:00          0.062             -0.5267  \n",
       "2019-06-04 11:45:00+00:00          0.109             -0.3788  \n",
       "2019-06-04 17:07:00+00:00          0.180              0.6908  \n",
       "2019-06-11 13:14:00+00:00          0.202             -0.1280  \n",
       "2019-06-18 08:27:00+00:00          0.207             -0.1531  \n",
       "2019-06-19 08:58:00+00:00          0.226             -0.1531  \n",
       "2019-06-19 19:43:00+00:00          0.000              0.0000  \n",
       "2019-06-22 19:07:00+00:00          0.000              0.0000  \n",
       "2019-07-27 18:32:00+00:00          0.000             -0.1280  \n",
       "2019-07-29 11:02:00+00:00          0.000              0.0000  \n",
       "2019-07-31 12:18:00+00:00          0.000              0.0000  \n",
       "2019-08-14 08:40:00+00:00          0.089             -0.5267  \n",
       "2019-08-29 18:57:00+00:00          0.000              0.0000  \n",
       "2019-08-30 08:04:00+00:00          0.286              0.3818  \n",
       "2019-09-10 14:30:00+00:00          0.127              0.3612  \n",
       "2019-09-17 10:45:00+00:00          0.227              0.4767  \n",
       "2019-09-17 15:56:00+00:00          0.307              0.7269  \n",
       "2019-09-20 11:46:00+00:00          0.137              0.4019  \n",
       "2019-09-30 10:47:00+00:00          0.000              0.0000  \n",
       "2019-10-03 15:45:00+00:00          0.000              0.0000  \n",
       "2019-10-03 19:49:00+00:00          0.127              0.1531  \n",
       "2019-10-08 15:08:00+00:00          0.263              0.1280  \n",
       "2019-10-11 15:19:00+00:00          0.157              0.7574  \n",
       "2019-10-17 11:21:00+00:00          0.000              0.0000  \n",
       "2019-10-18 11:00:00+00:00          0.135              0.5574  \n",
       "2019-10-18 18:48:00+00:00          0.000             -0.3818  \n",
       "2019-10-28 15:56:00+00:00          0.000              0.0000  \n",
       "2019-10-29 08:57:00+00:00          0.000              0.0000  "
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# select only april 2021 to may 2021\n",
    "# merc_df_apr = merc_df.loc['2021-02-01':'2021-06-31']\n",
    "# use datetime index to filter\n",
    "merc_df_apr = merc_df[(merc_df.index >= '2019-05-31')]\n",
    "merc_df_apr.head(30)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>headline</th>\n",
       "      <th>sentiment</th>\n",
       "      <th>neg_sentiment</th>\n",
       "      <th>neu_sentiment</th>\n",
       "      <th>pos_sentiment</th>\n",
       "      <th>compound_sentiment</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>date</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2019-01-14 22:02:00+00:00</th>\n",
       "      <td>Merck Reports KEYTRUDA Reduced Risk Of Death By 31% Vs Chemotherapy In Previously-Treated Patients With Advanced Esophageal, E...</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.207</td>\n",
       "      <td>0.724</td>\n",
       "      <td>0.069</td>\n",
       "      <td>-0.6124</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-02-01 09:46:00+00:00</th>\n",
       "      <td>12 Stocks To Watch For February 1, 2019</td>\n",
       "      <td>neutral</td>\n",
       "      <td>0.000</td>\n",
       "      <td>1.000</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.0000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-02-01 14:10:00+00:00</th>\n",
       "      <td>The Daily Biotech Pulse: Merck Earnings, Positive Relaunch Of  Titan's Opioid Disorder Treatment Implant</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.148</td>\n",
       "      <td>0.656</td>\n",
       "      <td>0.197</td>\n",
       "      <td>0.2263</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-02-05 11:49:00+00:00</th>\n",
       "      <td>FDA Accepts For Review New Drug Application For Merck's Investigational Combination Of Imipenem/Cilastatin And Relebactam; Acc...</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.892</td>\n",
       "      <td>0.108</td>\n",
       "      <td>0.3182</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-02-05 13:39:00+00:00</th>\n",
       "      <td>Codexis shares are trading higher after the company reported a multi-year agreement with Merck to perform technology upgrades.</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.735</td>\n",
       "      <td>0.265</td>\n",
       "      <td>0.6597</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-02-21 13:09:00+00:00</th>\n",
       "      <td>31 Stocks Moving In Thursday's Pre-Market Session</td>\n",
       "      <td>neutral</td>\n",
       "      <td>0.000</td>\n",
       "      <td>1.000</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.0000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-02-22 10:02:00+00:00</th>\n",
       "      <td>65 Biggest Movers From Yesterday</td>\n",
       "      <td>neutral</td>\n",
       "      <td>0.000</td>\n",
       "      <td>1.000</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.0000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-02-25 13:56:00+00:00</th>\n",
       "      <td>Pharma M&amp;A Wave: Spark Therapeutics, Clementia Pharma Among The Rare Disease Biotechs Acquired</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.863</td>\n",
       "      <td>0.137</td>\n",
       "      <td>0.2263</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-02-26 09:01:00+00:00</th>\n",
       "      <td>AstraZeneca, Merck Announce Phase III POLO Trial Met its Primary Endpoint of Progression-free Survival</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.000</td>\n",
       "      <td>1.000</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.0000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-03-22 12:16:00+00:00</th>\n",
       "      <td>The Daily Biotech Pulse: Immutep Gets US Patent, Conatus NASH Disappointment, Eisai Moves On After Aducanumab Setback</td>\n",
       "      <td>neutral</td>\n",
       "      <td>0.171</td>\n",
       "      <td>0.829</td>\n",
       "      <td>0.000</td>\n",
       "      <td>-0.5106</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-03-23 16:20:00+00:00</th>\n",
       "      <td>The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs</td>\n",
       "      <td>neutral</td>\n",
       "      <td>0.000</td>\n",
       "      <td>1.000</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.0000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-03-29 17:55:00+00:00</th>\n",
       "      <td>Congo Health Ministry Says Has Recorded 15 New Confirmed Cases Of Ebola</td>\n",
       "      <td>neutral</td>\n",
       "      <td>0.000</td>\n",
       "      <td>1.000</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.0000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-04-11 16:33:00+00:00</th>\n",
       "      <td>NYC Mandates Measles Vaccinations; Merck Is The Exclusive Manufacturer</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.842</td>\n",
       "      <td>0.158</td>\n",
       "      <td>0.1280</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-04-18 14:51:00+00:00</th>\n",
       "      <td>Shares of several drug companies are trading lower amid continued efforts from Washington to curb prescription drug prices. Th...</td>\n",
       "      <td>mildly bearish</td>\n",
       "      <td>0.182</td>\n",
       "      <td>0.764</td>\n",
       "      <td>0.054</td>\n",
       "      <td>-0.6369</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-04-22 10:47:00+00:00</th>\n",
       "      <td>Merck's KEYTRUDA in Combination with Inlyta Approved by the FDA as First-Line Treatment for Patients With Advanced Renal Cell ...</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.789</td>\n",
       "      <td>0.211</td>\n",
       "      <td>0.5859</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-05-02 12:06:00+00:00</th>\n",
       "      <td>UBS Maintains Buy on Merck &amp; Company, Inc. Common Stock (new), Raises Price Target to $88</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.000</td>\n",
       "      <td>1.000</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.0000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-05-16 18:50:00+00:00</th>\n",
       "      <td>5 ASCO Abstracts That Moved Stocks</td>\n",
       "      <td>neutral</td>\n",
       "      <td>0.000</td>\n",
       "      <td>1.000</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.0000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-05-20 18:28:00+00:00</th>\n",
       "      <td>Argus Questions Logic Behind Bristol-Myers' Proposed Celgene Buy, Steps To Sidelines</td>\n",
       "      <td>mildly bearish</td>\n",
       "      <td>0.000</td>\n",
       "      <td>1.000</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.0000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-05-22 16:38:00+00:00</th>\n",
       "      <td>Merck's Keytruda Vs. Bristol-Myers Squibb's Opdivo In Q1 And Beyond</td>\n",
       "      <td>neutral</td>\n",
       "      <td>0.000</td>\n",
       "      <td>1.000</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.0000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-05-31 10:46:00+00:00</th>\n",
       "      <td>Merck Reports KEYTRUDA Showed Improved Overall Survival as First-Line Treatment of Recurrent or Metastatic Head and Neck Squam...</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.897</td>\n",
       "      <td>0.103</td>\n",
       "      <td>0.4767</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-06-01 11:36:00+00:00</th>\n",
       "      <td>Merck Announces Five-Year Survival Data for KEYTRUDA in Advanced Non-Small Cell Lung Cancer from First KEYNOTE Trial at #ASCO19</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.188</td>\n",
       "      <td>0.726</td>\n",
       "      <td>0.085</td>\n",
       "      <td>-0.5267</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-06-03 20:15:00+00:00</th>\n",
       "      <td>Merck Reports LYNPARZA Phase 3 SOLO3 Trial Showed 72% Objective Response Rate in Patients with Platinum-Sensitive Relapsed Ger...</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.136</td>\n",
       "      <td>0.802</td>\n",
       "      <td>0.062</td>\n",
       "      <td>-0.5267</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-06-04 11:45:00+00:00</th>\n",
       "      <td>The Daily Biotech Pulse: ASCO Presentations From Roche, Celgene &amp; More, Edwards Recommends Rejection Of Mini-Tender Offer</td>\n",
       "      <td>neutral</td>\n",
       "      <td>0.189</td>\n",
       "      <td>0.702</td>\n",
       "      <td>0.109</td>\n",
       "      <td>-0.3788</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-06-04 17:07:00+00:00</th>\n",
       "      <td>Shares of several healthcare companies are trading higher with the overall US market. Recent comments out of China and Mexico ...</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.820</td>\n",
       "      <td>0.180</td>\n",
       "      <td>0.6908</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-06-11 13:14:00+00:00</th>\n",
       "      <td>FDA Greenlights Merck's Blockbuster Drug Keytruda For First-Line Treatment Of Head, Neck Cancer</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.228</td>\n",
       "      <td>0.570</td>\n",
       "      <td>0.202</td>\n",
       "      <td>-0.1280</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-06-18 08:27:00+00:00</th>\n",
       "      <td>AstraZeneca, Merck Announce Lynparza Approved in the EU for 1st-line Maintenance Treatment Of BRCA-mutated Advanced Ovarian Ca...</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.190</td>\n",
       "      <td>0.603</td>\n",
       "      <td>0.207</td>\n",
       "      <td>-0.1531</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-06-19 08:58:00+00:00</th>\n",
       "      <td>AstraZeneca,Merck Announce Lynparza Approved in Japan for 1st-line Maintenance Therapy in BRCA-mutated Advanced Ovarian Cancer</td>\n",
       "      <td>mildly bullish</td>\n",
       "      <td>0.208</td>\n",
       "      <td>0.566</td>\n",
       "      <td>0.226</td>\n",
       "      <td>-0.1531</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-06-19 19:43:00+00:00</th>\n",
       "      <td>Report: Merck Searching Internally For Next CEO</td>\n",
       "      <td>neutral</td>\n",
       "      <td>0.000</td>\n",
       "      <td>1.000</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.0000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-06-22 19:07:00+00:00</th>\n",
       "      <td>The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs</td>\n",
       "      <td>neutral</td>\n",
       "      <td>0.000</td>\n",
       "      <td>1.000</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0.0000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2019-07-27 18:32:00+00:00</th>\n",
       "      <td>The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate</td>\n",
       "      <td>neutral</td>\n",
       "      <td>0.143</td>\n",
       "      <td>0.857</td>\n",
       "      <td>0.000</td>\n",
       "      <td>-0.1280</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                    headline  \\\n",
       "date                                                                                                                                                           \n",
       "2019-01-14 22:02:00+00:00  Merck Reports KEYTRUDA Reduced Risk Of Death By 31% Vs Chemotherapy In Previously-Treated Patients With Advanced Esophageal, E...   \n",
       "2019-02-01 09:46:00+00:00                                                                                            12 Stocks To Watch For February 1, 2019   \n",
       "2019-02-01 14:10:00+00:00                           The Daily Biotech Pulse: Merck Earnings, Positive Relaunch Of  Titan's Opioid Disorder Treatment Implant   \n",
       "2019-02-05 11:49:00+00:00  FDA Accepts For Review New Drug Application For Merck's Investigational Combination Of Imipenem/Cilastatin And Relebactam; Acc...   \n",
       "2019-02-05 13:39:00+00:00     Codexis shares are trading higher after the company reported a multi-year agreement with Merck to perform technology upgrades.   \n",
       "2019-02-21 13:09:00+00:00                                                                                  31 Stocks Moving In Thursday's Pre-Market Session   \n",
       "2019-02-22 10:02:00+00:00                                                                                                   65 Biggest Movers From Yesterday   \n",
       "2019-02-25 13:56:00+00:00                                     Pharma M&A Wave: Spark Therapeutics, Clementia Pharma Among The Rare Disease Biotechs Acquired   \n",
       "2019-02-26 09:01:00+00:00                             AstraZeneca, Merck Announce Phase III POLO Trial Met its Primary Endpoint of Progression-free Survival   \n",
       "2019-03-22 12:16:00+00:00              The Daily Biotech Pulse: Immutep Gets US Patent, Conatus NASH Disappointment, Eisai Moves On After Aducanumab Setback   \n",
       "2019-03-23 16:20:00+00:00                                            The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs   \n",
       "2019-03-29 17:55:00+00:00                                                            Congo Health Ministry Says Has Recorded 15 New Confirmed Cases Of Ebola   \n",
       "2019-04-11 16:33:00+00:00                                                             NYC Mandates Measles Vaccinations; Merck Is The Exclusive Manufacturer   \n",
       "2019-04-18 14:51:00+00:00  Shares of several drug companies are trading lower amid continued efforts from Washington to curb prescription drug prices. Th...   \n",
       "2019-04-22 10:47:00+00:00  Merck's KEYTRUDA in Combination with Inlyta Approved by the FDA as First-Line Treatment for Patients With Advanced Renal Cell ...   \n",
       "2019-05-02 12:06:00+00:00                                          UBS Maintains Buy on Merck & Company, Inc. Common Stock (new), Raises Price Target to $88   \n",
       "2019-05-16 18:50:00+00:00                                                                                                 5 ASCO Abstracts That Moved Stocks   \n",
       "2019-05-20 18:28:00+00:00                                               Argus Questions Logic Behind Bristol-Myers' Proposed Celgene Buy, Steps To Sidelines   \n",
       "2019-05-22 16:38:00+00:00                                                                Merck's Keytruda Vs. Bristol-Myers Squibb's Opdivo In Q1 And Beyond   \n",
       "2019-05-31 10:46:00+00:00  Merck Reports KEYTRUDA Showed Improved Overall Survival as First-Line Treatment of Recurrent or Metastatic Head and Neck Squam...   \n",
       "2019-06-01 11:36:00+00:00    Merck Announces Five-Year Survival Data for KEYTRUDA in Advanced Non-Small Cell Lung Cancer from First KEYNOTE Trial at #ASCO19   \n",
       "2019-06-03 20:15:00+00:00  Merck Reports LYNPARZA Phase 3 SOLO3 Trial Showed 72% Objective Response Rate in Patients with Platinum-Sensitive Relapsed Ger...   \n",
       "2019-06-04 11:45:00+00:00          The Daily Biotech Pulse: ASCO Presentations From Roche, Celgene & More, Edwards Recommends Rejection Of Mini-Tender Offer   \n",
       "2019-06-04 17:07:00+00:00  Shares of several healthcare companies are trading higher with the overall US market. Recent comments out of China and Mexico ...   \n",
       "2019-06-11 13:14:00+00:00                                    FDA Greenlights Merck's Blockbuster Drug Keytruda For First-Line Treatment Of Head, Neck Cancer   \n",
       "2019-06-18 08:27:00+00:00  AstraZeneca, Merck Announce Lynparza Approved in the EU for 1st-line Maintenance Treatment Of BRCA-mutated Advanced Ovarian Ca...   \n",
       "2019-06-19 08:58:00+00:00     AstraZeneca,Merck Announce Lynparza Approved in Japan for 1st-line Maintenance Therapy in BRCA-mutated Advanced Ovarian Cancer   \n",
       "2019-06-19 19:43:00+00:00                                                                                    Report: Merck Searching Internally For Next CEO   \n",
       "2019-06-22 19:07:00+00:00                                              The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs   \n",
       "2019-07-27 18:32:00+00:00                                                            The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate   \n",
       "\n",
       "                                sentiment  neg_sentiment  neu_sentiment  \\\n",
       "date                                                                      \n",
       "2019-01-14 22:02:00+00:00  mildly bullish          0.207          0.724   \n",
       "2019-02-01 09:46:00+00:00         neutral          0.000          1.000   \n",
       "2019-02-01 14:10:00+00:00  mildly bullish          0.148          0.656   \n",
       "2019-02-05 11:49:00+00:00  mildly bullish          0.000          0.892   \n",
       "2019-02-05 13:39:00+00:00  mildly bullish          0.000          0.735   \n",
       "2019-02-21 13:09:00+00:00         neutral          0.000          1.000   \n",
       "2019-02-22 10:02:00+00:00         neutral          0.000          1.000   \n",
       "2019-02-25 13:56:00+00:00  mildly bullish          0.000          0.863   \n",
       "2019-02-26 09:01:00+00:00  mildly bullish          0.000          1.000   \n",
       "2019-03-22 12:16:00+00:00         neutral          0.171          0.829   \n",
       "2019-03-23 16:20:00+00:00         neutral          0.000          1.000   \n",
       "2019-03-29 17:55:00+00:00         neutral          0.000          1.000   \n",
       "2019-04-11 16:33:00+00:00  mildly bullish          0.000          0.842   \n",
       "2019-04-18 14:51:00+00:00  mildly bearish          0.182          0.764   \n",
       "2019-04-22 10:47:00+00:00  mildly bullish          0.000          0.789   \n",
       "2019-05-02 12:06:00+00:00  mildly bullish          0.000          1.000   \n",
       "2019-05-16 18:50:00+00:00         neutral          0.000          1.000   \n",
       "2019-05-20 18:28:00+00:00  mildly bearish          0.000          1.000   \n",
       "2019-05-22 16:38:00+00:00         neutral          0.000          1.000   \n",
       "2019-05-31 10:46:00+00:00  mildly bullish          0.000          0.897   \n",
       "2019-06-01 11:36:00+00:00  mildly bullish          0.188          0.726   \n",
       "2019-06-03 20:15:00+00:00  mildly bullish          0.136          0.802   \n",
       "2019-06-04 11:45:00+00:00         neutral          0.189          0.702   \n",
       "2019-06-04 17:07:00+00:00  mildly bullish          0.000          0.820   \n",
       "2019-06-11 13:14:00+00:00  mildly bullish          0.228          0.570   \n",
       "2019-06-18 08:27:00+00:00  mildly bullish          0.190          0.603   \n",
       "2019-06-19 08:58:00+00:00  mildly bullish          0.208          0.566   \n",
       "2019-06-19 19:43:00+00:00         neutral          0.000          1.000   \n",
       "2019-06-22 19:07:00+00:00         neutral          0.000          1.000   \n",
       "2019-07-27 18:32:00+00:00         neutral          0.143          0.857   \n",
       "\n",
       "                           pos_sentiment  compound_sentiment  \n",
       "date                                                          \n",
       "2019-01-14 22:02:00+00:00          0.069             -0.6124  \n",
       "2019-02-01 09:46:00+00:00          0.000              0.0000  \n",
       "2019-02-01 14:10:00+00:00          0.197              0.2263  \n",
       "2019-02-05 11:49:00+00:00          0.108              0.3182  \n",
       "2019-02-05 13:39:00+00:00          0.265              0.6597  \n",
       "2019-02-21 13:09:00+00:00          0.000              0.0000  \n",
       "2019-02-22 10:02:00+00:00          0.000              0.0000  \n",
       "2019-02-25 13:56:00+00:00          0.137              0.2263  \n",
       "2019-02-26 09:01:00+00:00          0.000              0.0000  \n",
       "2019-03-22 12:16:00+00:00          0.000             -0.5106  \n",
       "2019-03-23 16:20:00+00:00          0.000              0.0000  \n",
       "2019-03-29 17:55:00+00:00          0.000              0.0000  \n",
       "2019-04-11 16:33:00+00:00          0.158              0.1280  \n",
       "2019-04-18 14:51:00+00:00          0.054             -0.6369  \n",
       "2019-04-22 10:47:00+00:00          0.211              0.5859  \n",
       "2019-05-02 12:06:00+00:00          0.000              0.0000  \n",
       "2019-05-16 18:50:00+00:00          0.000              0.0000  \n",
       "2019-05-20 18:28:00+00:00          0.000              0.0000  \n",
       "2019-05-22 16:38:00+00:00          0.000              0.0000  \n",
       "2019-05-31 10:46:00+00:00          0.103              0.4767  \n",
       "2019-06-01 11:36:00+00:00          0.085             -0.5267  \n",
       "2019-06-03 20:15:00+00:00          0.062             -0.5267  \n",
       "2019-06-04 11:45:00+00:00          0.109             -0.3788  \n",
       "2019-06-04 17:07:00+00:00          0.180              0.6908  \n",
       "2019-06-11 13:14:00+00:00          0.202             -0.1280  \n",
       "2019-06-18 08:27:00+00:00          0.207             -0.1531  \n",
       "2019-06-19 08:58:00+00:00          0.226             -0.1531  \n",
       "2019-06-19 19:43:00+00:00          0.000              0.0000  \n",
       "2019-06-22 19:07:00+00:00          0.000              0.0000  \n",
       "2019-07-27 18:32:00+00:00          0.000             -0.1280  "
      ]
     },
     "execution_count": 33,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "merc_df_apr = merc_df[(merc_df.index >= '2019-01-01')]\n",
    "merc_df_apr.head(30)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "## Project is based on lesson 6.03 and 6.04 NLP and NLTK"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "ga",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
